According to our trajectory analysis for IPF patients, enhanced expression of CCL2 was found in activated fibrotic cells and macrophages from IPF patients, respectively (Figure 3F and S3E–S3I). This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.